Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI reads heart scans to spot hidden inflammation

NCT ID NCT07220304

Knowledge-focused Sponsor: Corazon Medical PC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will see if an artificial intelligence program called CaRi-Heart can help doctors make better decisions about treating heart disease. About 15,000 adults getting a standard heart CT scan will have their images re-analyzed by the AI at no extra cost. The goal is to find out if the AI's extra information leads to earlier or more effective treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 15,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Clinically indicated CCTA undertaken for evaluation of coronary artery disease. 2. Ability to provide written informed consent 3. Patient between 18 and 80 years old Exclusion Criteria: \- 1. History of surgical revascularization (coronary artery bypass graft, CABG) 2. CCTA undertaken for structural heart disease evaluation (e.g. transcatheter aortic valve replacement (TAVR) 3. The CCTA is of poor quality or partly unanalysable due to artifacts, such as motion-artifacts, breathing-artifacts, stack-artifacts or blooming-artifacts. 4\. Inability to provide required health information 5. Pregnancy or any known contraindication for CCTA

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atherosclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atherosclerosis coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atherosclerosis Cardiovascular inflammation Coronary artery disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Corazon Imaging

    Bay City, Michigan, 48124, United States

  • Corazon Imaging

    Berkley, Michigan, 48072, United States

  • Corazon Imaging

    Caro, Michigan, 48723, United States

  • Corazon Imaging

    Dearborn, Michigan, 48124, United States

  • Corazon Imaging

    Flint, Michigan, 48532, United States

  • Corazon Imaging

    Grand Rapids, Michigan, 49546, United States

  • Corazon Imaging

    Livonia, Michigan, 48154, United States

  • Corazon Imaging

    Macomb, Michigan, 48044, United States

  • Corazon Imaging

    Madison Heights, Michigan, 48071, United States

  • Corazon Imaging

    Mount Pleasant, Michigan, 48858, United States

  • Corazon Imaging

    Novi, Michigan, 48377, United States

  • Corazon Imaging

    Saginaw, Michigan, 48603, United States

  • Corazon Imaging

    Saint Clair Shores, Michigan, 48080, United States

  • Corazon Imaging

    Sterling Heights, Michigan, 48310, United States

  • Corazon Imaging

    Trenton, Michigan, 48183, United States

  • Corazon Imaging

    Waterford, Michigan, 48327, United States

  • Corazon Imaging

    Elizabethtown, Pennsylvania, 17022, United States

  • Corazon Imaging

    Lemoyne, Pennsylvania, 17043, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.